Offstream
news

The American Cancer Society adds the FDA-approved Guardant Health Shield blood test to its recommended colorectal cancer screening options in the United States amidst a rise in colon cancer cases in young adults.
2026-05-27

The European Commission approves the use of Lecanemab, a monoclonal antibody medication that targets amyloid beta peptides, to treat the early stages of Alzheimer's disease via intravenous therapy. This is the first drug to be approved to treat the disease in Europe, and was approved by the Food and Drug Administration in the United States in 2023.
2025-04-15

The U.S. Food and Drug Administration (FDA) approves Neuralink's first-in-human clinical study of brain implants to treat conditions such as paralysis and blindness.
2023-05-25

The Food and Drug Administration authorizes the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11, becoming the first vaccine to be approved for children in the United States.
2021-10-29

The Food and Drug Administration gives full approval to the Pfizer–BioNTech COVID-19 vaccine, becoming the first vaccine in the U.S. to be granted full licensure and thereby giving businesses, schools and universities more confidence to adopt vaccine mandates.
2021-08-23

The U.S. Food and Drug Administration says that it has granted priority review for the vaccine developed by Pfizer and BioNTech. A decision on whether to fully approve the vaccine will likely be made within two months.
2021-07-16

The Food and Drug Administration approves remdesivir to treat COVID-19 in hospitalized patients. The drug, manufactured by the pharmaceutical company Gilead under the brand name Veklury, is the first fully approved COVID-19 treatment in the United States.
2020-10-22

The United States Food and Drug Administration approves the Merck & Co. drug, Bridion, that reverses the effects of muscle relaxants used during surgery.
2015-12-15

The United States Food and Drug Administration approves marketing of a cooling cap system to reduce hair loss in female breast cancer patients during chemotherapy. The DigniCap scalp cooling system, a product first available in Sweden in the 1990s, produces near-freezing temperatures that make it harder for cancer-fighting drugs to reach and harm hair follicles. [https:--www.usnews.com-news-politics-articles-2015-12-08-fda-clears-cold-cap-to-save-hair-during-breast-cancer-chemo (AP via U.S. News and World Report)] [http:--www.fda.gov-NewsEvents-Newsroom-PressAnnouncements-ucm476216.htm (FDA)] [http:--www.dignicap.com-dignitana-fda-clearance- (DigniCap)]date=August 2019
2015-12-8

The U.S. Food and Drug Administration orders R. J. Reynolds Tobacco Company to stop further U.S. sale and distribution of four cigarette products because they may be more dangerous than similar older cigarettes.
2015-09-15